295.61 0.00 (0.00%)
After hours: 4:52PM EDT
|Bid||296.14 x 800|
|Ask||296.41 x 800|
|Day's Range||292.80 - 297.84|
|52 Week Range||226.02 - 309.99|
|Beta (3Y Monthly)||1.14|
|PE Ratio (TTM)||74.74|
|Forward Dividend & Yield||1.36 (0.48%)|
|1y Target Est||N/A|
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
Teleflex Inc NYSE:TFXView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low and declining Bearish sentimentShort interest | PositiveShort interest is extremely low for TFX with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting TFX. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $1.42 billion over the last one-month into ETFs that hold TFX are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Industrials sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Investors still seem disappointed after the Federal Reserve dampened hopes for an interest-rate cut in the near future, especially with the global economy looking weak once more.
KLA-Tencor's (KLAC) fiscal third-quarter earnings are likely to benefit from solid product portfolio. However, memory weakness and intensifying competition may impact its results.
Teleflex (TFX) delivered earnings and revenue surprises of 3.70% and 1.00%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Wayne, Pennsylvania-based company said it had net income of 87 cents. Earnings, adjusted for amortization costs and restructuring costs, came to $2.24 per share. The results surpassed ...
Better-than-expected performance at Pharmaceutical Distribution and World Courier and higher revenues might aid AmerisourceBergen (ABC) in Q2 earnings. However, stiff competition might be a dampener.
Fitbit's (FIT) focus on innovation, including new smartwatches, is likely to benefit first-quarter results. However, intensifying competition in the wearables market remains a major concern.
Better-than-expected performance at mass cytometry market and higher revenues is likely to aid Fluidigm's (FLDM) in Q1 earnings. However, sluggishness in microfluidics market remains a dampener.
Higher Consumable revenues, product innovation and focus on R&D likely to aid DENTSPLY SIRONA (XRAY) in Q1 earnings. However, contraction is gross margin might be a dampener.
Better-than-expected performance at C&V and Cardiac & Neuromodulation product lines and higher revenues might aid Integer Holdings (ITGR) in Q1. But decline in non-medical sales might be a dampener.
Teleflex (TFX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll apply a basic P/E ratio analysis to Teleflex Incorporated's (NYSE:TFX), to help you decide if the stock is worth further research...
Strong analytical instruments business, product portfolio expansion and prudent growth strategy are likely to support Thermo Fisher (TMO) in Q1. However, forex might act as a dampener.
Higher Invisalign case volume, solid show by Clear Aligner segment and anticipated sturdy growth at Scanner and Service business are likely to support Align Technology (ALGN) in Q1. However, operating expenses are likely to act as dampeners.
While the market driven by short-term sentiment influenced by uncertainty regarding the future of the interest rate environment in the US, declining oil prices and the trade war with China, many smart money investors kept their optimism regarding the current bull run in the fourth quarter, while still hedging many of their long positions. However, […]
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Measuring Teleflex Incorporated's (NYSE:TFX) track record of past performance is an insightful exercise for investors. It ena...
Consensus expectations for Teleflex Incorporated (NYSE: TFX ) imply an improvement in revenue growth from an estimated 6.5 percent in 2019 to 7.2 percent in 2020, according to Raymond James. New product ...